The global clinical trial packaging market is projected to reach a substantial $9.12 billion by 2034, driven by a surge in drug trials, patient-centric packaging demands, and the integration of advanced technologies. North America currently dominates the market, but the Asia-Pacific region is poised for rapid growth.